Yue Hao

16PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 05, 2026
Clinicopathologic and molecular features of head and neck NUT carcinoma: Analysis of 25 cases, including 5 with adenoid differentiation.

|Oct 01, 2025
Epidemiology and clinical characteristics of mesothelioma in the Chinese population: a multicenter study.

Shengjie Yang, Yue Hao, Ke Wang

|May 30, 2024
Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases.

Yue Hao, Manyi Xu, Xiaohong Zeng

|May 25, 2024
Pyrotinib as a salvage treatment for patients with HER-2 positive advanced lung adenocarcinoma after the progression of afatinib treatment.

Manyi Xu, Yanhua Wang, Keda Shao

|May 13, 2024
Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterations.

Yanhua Wang, Manyi Xu, Ke Wang

|Apr 16, 2024
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations.

Yanhua Wang, Jingwen Wei, Manyi Xu

Pageof 3

Frequent Collaborators

6 joint publications

Chunwei Xu

5 joint publications

Wenxian Wang

4 joint publications

Yongchang Zhang

4 joint publications

Zhengbo Song